Pylarify (piflufolastat f 18)
Ended Awarded Last action
- Contract number
- 36C25225N0508
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $2,002,840
Award facts
- Contract value 65% obligated
-
- $2,002,839.60 Current, with exercised options
- $3,085,455.60 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $126,305 | |
| Exercise an Option | $902,180 | |
| Original award | $974,354 |
About this award
Veterans Integrated Service Network 12 issued a delivery order to Progenics Pharmaceuticals Inc. on September 1, 2025, with a ceiling value of $3,085,455.60 for PYLARIFY (piflufolastat F-18), a radiopharmaceutical diagnostic imaging agent for positron emission tomography scans, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
The order executes the first option year and runs through August 31, 2027. Place of performance is North Billerica, Massachusetts. Pricing is firm fixed price with no set-aside designation. Progenics Pharmaceuticals Inc. is a division of Lantheus Medical Imaging, Inc., and manufactures PYLARIFY as a sole-source supplier for this diagnostic application to federal healthcare providers.
Quick answers
Who was awarded contract 36C25225N0508?
36C25225N0508 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 1, 2025.
How much is contract 36C25225N0508 worth?
The government has obligated $2,002,840 on 36C25225N0508. Its potential value, with all options, is $3,085,456.
Is contract 36C25225N0508 an order under another contract?
Yes. 36C25225N0508 is a delivery order under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25225N0508 competed?
The extent of competition for 36C25225N0508 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award